News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Meridian Bioscience, Inc. (VIVO) Completes Acquisition Of O.E.M. Concepts, Inc. And Comments On New Growth Opportunities



10/19/2005 5:12:36 PM

CINCINNATI--(BUSINESS WIRE)--Feb. 1, 2005--Meridian Bioscience, Inc., (NASDAQ:VIVO) today announced that it has completed the purchase of O.E.M. Concepts, Inc., highlights include: -- purchase price of $6.0 million in cash and a performance based earnout opportunity of $2.3 million over a four-year period, as previously reported; -- earnings accretion of between $0.01 and $0.02 for the balance of fiscal 2005 and $0.04 to $0.06 for fiscal 2006 with continued growth and higher earnings contributions anticipated; -- O.E.M.'s management team to remain with the Company thereby enhancing Meridian's Life Science business; -- proprietary know-how and technological capabilities that fit well with and add to Meridian's Viral Antigens and BIODESIGN International subsidiaries; and -- complements Meridian's entry into the important and growing market for products addressing the bioterrorism threat and related U.S. Government business.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES